Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets
Increased availability of large-scale molecular profiling has enabled system-level monitoring of molecular effects of candidate therapeutics. Here, the authors take advantage of such data to show that the ability of a drug to reverse cancer-associated gene expression changes is indicative of itsin v...
Main Authors: | Bin Chen, Li Ma, Hyojung Paik, Marina Sirota, Wei Wei, Mei-Sze Chua, Samuel So, Atul J. Butte |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2017-07-01
|
Series: | Nature Communications |
Online Access: | https://doi.org/10.1038/ncomms16022 |
Similar Items
-
Correction: Corrigendum: Systematic pan-cancer analysis of tumour purity
by: Dvir Aran, et al.
Published: (2016-02-01) -
Ten years of pathway analysis: current approaches and outstanding challenges.
by: Purvesh Khatri, et al.
Published: (2012-01-01) -
Comprehensive analysis of normal adjacent to tumor transcriptomes
by: Dvir Aran, et al.
Published: (2017-10-01) -
Characteristics and challenges of the clinical pipeline of digital therapeutics
by: Nisarg A. Patel, et al.
Published: (2020-12-01) -
Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association.
by: Rong Chen, et al.
Published: (2010-10-01)